The shelf creates ongoing dilution overhang, particularly via the $80 million ATM facility. Monitor for any immediate drawdowns under the Jefferies agreement, as even small sales could pressure the stock given ANTX's $130 million market cap. The resale of 14 million shares by holders may also increase float and near-term supply.
Price Chart
Executive Summary
AN2 Therapeutics' shelf registration on Form S-3 has become effective, allowing the company to raise up to $300 million in aggregate through future offerings of common stock, including $80 million under an at-the-market (ATM) sales agreement with Jefferies. The shelf also covers resale of up to 14 million shares by existing securityholders.
Key Facts
- S-3 shelf registration became effective on April 20, 2026.
- Total capacity: $300 million in securities, including up to $80 million in common stock via ATM with Jefferies.
- Shelf includes resale of 14,035,104 shares by selling securityholders.
- This replaces a prior registration statement set to expire April 13, 2026.
Financial Impact
$300 million total potential capital raise, with $80 million available under ATM program; dilution risk begins upon first takedown.
Risk Factors
- Dilution risk from future equity raises under the shelf
- Increased share supply from resale of 14 million shares by securityholders
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001256 |
| Document: 9999999995-26-001256-index.html | 9999999995-26-001256 |
| Document: 9999999995-26-001256.txt | 9999999995-26-001256 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 10w ago | 8-K | $6.28 | awaiting T+60 | — | $3.63 (−42.20%) |
Jun 4, 2026 20w ago | 8-K | $3.82 $5.55 | ▲ +45.29% | ▲ +41.29% | $3.63 (−4.97%) |
Apr 22, 2026 26w ago | DEFA14A | $4.28 $4.80 | ▲ +12.15% | ▲ +7.13% | $3.63 (−15.19%) |
Apr 21, 2026 26w ago | EFFECT | $3.80 $4.67 | ▲ +22.89% | ▲ +16.00% | $3.63 (−4.47%) |
Apr 20, 2026 27w ago | 424B5 | $3.80 $4.67 | ▼ −22.89% | ▼ −16.00% | $3.63 (+4.47%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers